Key result
Third-generation implantable cardioverter defibrillator therapy was associated with one or more complications in 28% of patients over 21 months, most frequently inappropriate shocks (16%).
Observational (n=144)
Third-generation ICDs are associated with a low risk of serious complications such as perioperative death or infection, though inappropriate shocks and lead-related issues remain relatively common.
No takes yet. Share an insight, caveat, or question.
Warrants ongoing vigilance in ICD follow-up; leaves open applicability to contemporary devices and populations.
Grimm et al. (1999) conducted an observational in Patients undergoing first implant of third-generation ICDs (n=144). Third-generation implantable cardioverter defibrillator (ICD) therapy was evaluated on Incidence of complications. Third-generation implantable cardioverter defibrillator therapy was associated with one or more complications in 28% of patients over 21 months, most frequently inappropriate shocks (16%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: